Ageing Americans may not get results of Alzheimer's study due to Trump cuts
2 hours ago
- Trump administration funding cuts may force researchers to close an Alzheimer's study on 600 aging participants without sharing cognitive test results.
- The cuts disrupted over 5,700 NIH grants, affecting more than 74,000 clinical trial participants nationally.
- Early diagnosis of Alzheimer's is critical, but the closure delays detection for participants in low-income, majority Black neighborhoods.
- The cancellations are part of a broader effort to eliminate DEI initiatives, which researchers argue conflates health equity with politics.
- Black Americans are twice as likely to develop Alzheimer's but are underrepresented in studies; this research focused on historically red-lined areas.
- Participants and researchers view the cancellation as political retribution for studying links between structural racism and health.